Any current/future new fundraising through debt or equity?

The company is undertaking CAPEX funded through a mix of internal accruals and borrowings. They expect to continue being net debt free despite some borrowings for CAPEX. Current gross debt stands at Rs. 140 crores consolidated. The borrowings include term loans with an interest rate around 9%. No explicit mention of raising funds through equity in the transcript. The management emphasizes a conservative approach to margins and financial management but did not indicate plans for equity fundraising. Overall, future fundraising appears focused on debt (term loans) to support CAPEX, with no curren

Any current/future capex/capital investment/strategic investment?

Current CAPEX includes: - Egypt plant: Rs. 120 crore (around Rs. 70 crore spent so far) - India (Mundra) plant: Rs. 125 crore (around Rs. 90 crore spent so far) Capacity additions: - Egypt: 120,000 units - Mundra, India: 200,000 units Egypt plant expected to start trial production in Oct-Nov 2025, with commercial production likely within 2-3 months after; major impact visible from FY27. Mundra plant expected to be ready by last quarter of FY26, with commercial production starting before year-end. CAPEX funded through internal accruals and borrowings; company aims to remain net debt fre

Future growth expectations in sales/revenue/volumes?

India Business Growth: Expected 10% - 15% growth in sales/revenue for the coming quarters and FY26 (Page 6). Margin Expectations: Sustainable margins around 13% - 14% in India, with efforts to achieve higher but conservative guidance maintained (Page 6 and 8). US Business: Strong order book (~USD 70 million) and expected to continue delivering good margins and growth, with a planned product pipeline for 1.5-2 years (Page 4). Egypt and Mundra Facilities: Capacity additions of 120,000 cylinders (Egypt) and 200,000 cylinders (Mundra) with commercial production starting within FY26; significant re

Future growth expectations in earnings/operating earnings/profits/EPS?

India business growth expected at 10%-15% annually going forward. India business sustainable margins targeted conservatively at 13%-14%, despite recent sharp rise to 17%. US business expected to sustain good margins based on management discussions. UAE business expected to remain moderate with ongoing challenges. Capacity expansions in Mundra (India) and Egypt to come onstream during current fiscal, with significant impact visible from FY27 onwards. New sectors like biogas and semiconductors seen as growth opportunities with potential for future expansion. Overall, with healthy dem

Current/ Expected Orderbook/ Pending Orders?

The current order book in India business is around Rs. 60 crore, and the company continuously receives and executes orders to maintain this level. For the US business, the order book stands at approximately USD 70 million, with products planned for 1.5 to 2 years ahead. The US market order book is dynamic, with continuous execution and incoming new orders. The company expects steady growth in India business, projecting 10% to 15% growth supported by the current order book. No specific order book details for UAE or Egypt were provided, but Egypt's plant commissioning is anticipated in t

IN US

Sale is live|00:00:00left today

Everest Kanto Cylinder LtdQ2 FY25Industrial Manufacturing

Everest Kanto Cylinder Ltd Q2 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹123P/E: 10.9Market Cap: ₹1.3K CrSector: Industrial Manufacturing

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Yes

Order

Yes

Capex

Yes

3 of 5 growth signals are positive.

Full analysis

Revenue guidance

Category 3

→India Business Growth: Expected 10% - 15% growth in sales/revenue for the coming quarters and FY26 (Page 6).
→Margin Expectations: Sustainable margins around 13% - 14% in India, with efforts to achieve higher but conservative guidance maintained (Page 6 and 8).
→US Business: Strong order book (~USD 70 million) and expected to continue delivering good margins and growth, with a planned product pipeline for 1.5-2 years (Page 4).
→Egypt and Mundra Facilities: Capacity additions of 120,000 cylinders (Egypt) and 200,000 cylinders (Mundra) with commercial production starting within FY26; significant revenue impact expected from FY27 onwards (Page 4 and 7).
→Order Book: India maintains an order book around Rs. 60 crore consistently (Page 7).
→Overall, healthy demand visibility and capacity expansions position the company well for the next phase of growth (Page 3).

Margin guidance

Category 3

→India business growth expected at 10%-15% annually going forward.
→India business sustainable margins targeted conservatively at 13%-14%, despite recent sharp rise to 17%.
→US business expected to sustain good margins based on management discussions.
→UAE business expected to remain moderate with ongoing challenges.
→Capacity expansions in Mundra (India) and Egypt to come onstream during current fiscal, with significant impact visible from FY27 onwards.
→New sectors like biogas and semiconductors seen as growth opportunities with potential for future expansion.
→Overall, with healthy demand visibility, capacity additions, and expanding applications, company well-positioned for next phase of growth and value creation.
→CAPEX largely funded internally with some borrowing at ~9% interest rate, maintaining near net debt-free status.

3 more insights locked — sign up free to unlock

Fundraise plans

Yes

→The company is undertaking CAPEX funded through a mix of internal accruals and borrowings.
→They expect to continue being net debt free despite some borrowings for CAPEX.
→Current gross debt stands at Rs. 140 crores consolidated.
→The borrowings include term loans with an interest rate around 9%.
→No explicit mention of raising funds through equity in the transcript.
→The management emphasizes a conservative approach to margins and financial management but did not indicate plans for equity fundraising.
→Overall, future fundraising appears focused on debt (term loans) to support CAPEX, with no current plans stated for equity issuance.

Order book

Yes

→The current order book in India business is around Rs. 60 crore, and the company continuously receives and executes orders to maintain this level.
→For the US business, the order book stands at approximately USD 70 million, with products planned for 1.5 to 2 years ahead.
→The US market order book is dynamic, with continuous execution and incoming new orders.
→The company expects steady growth in India business, projecting 10% to 15% growth supported by the current order book.
→No specific order book details for UAE or Egypt were provided, but Egypt's plant commissioning is anticipated in the near term, potentially impacting orders in FY27.

Capex plans

Yes

→Current CAPEX includes:
→ - Egypt plant: Rs. 120 crore (around Rs. 70 crore spent so far)
→ - India (Mundra) plant: Rs. 125 crore (around Rs. 90 crore spent so far)
→Capacity additions:
→ - Egypt: 120,000 units
→ - Mundra, India: 200,000 units
→Egypt plant expected to start trial production in Oct-Nov 2025, with commercial production likely within 2-3 months after; major impact visible from FY27.
→Mundra plant expected to be ready by last quarter of FY26, with commercial production starting before year-end.
→CAPEX funded through internal accruals and borrowings; company aims to remain net debt free.
→Strategic focus remains on cylinder business with ongoing product development; exploring applications in CNG, hydrogen, biogas, and semiconductors.
→No current plans to move beyond the cylinder product line, but company investing in new tech and product roadmap within core business.

How does Everest Kanto Cylinder Ltd rank vs peers in Industrial Manufacturing?

Pro feature

1Everest Kanto Cylinder Ltd

Rev 3Mar 3

See full Industrial Manufacturing sector rankings

Want more stocks like Everest Kanto Cylinder Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio